Financials data is unavailable for this security.
View more
Year on year Lipocine Inc 's revenues fell -- from 500.00k to -2.85m. has fallen 51.99% from a loss of 10.76m to a larger loss of 16.35m.
| Gross margin | -- |
|---|---|
| Net profit margin | -176.80% |
| Operating margin | -202.19% |
| Return on assets | -31.72% |
|---|---|
| Return on equity | -34.12% |
| Return on investment | -34.05% |
More ▼
Cash flow in USDView more
In 2023, Lipocine Inc increased its cash reserves by 51.56%, or 1.62m. Cash Flow from Investing totalled 13.08m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 11.87m for operations while cash generated from financing totalled 404.57k.
| Cash flow per share | -1.59 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 3.97 |
|---|---|
| Tangible book value per share | 3.97 |
More ▼
Balance sheet in USDView more
| Current ratio | 12.56 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
